Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3356107
Max Phase: Preclinical
Molecular Formula: C28H20F3N3
Molecular Weight: 455.48
Molecule Type: Small molecule
Associated Items:
ID: ALA3356107
Max Phase: Preclinical
Molecular Formula: C28H20F3N3
Molecular Weight: 455.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: FC(F)(F)c1ccccc1-c1nc(NCc2ccc(-c3ccccc3)cc2)c2ccccc2n1
Standard InChI: InChI=1S/C28H20F3N3/c29-28(30,31)24-12-6-4-10-22(24)27-33-25-13-7-5-11-23(25)26(34-27)32-18-19-14-16-21(17-15-19)20-8-2-1-3-9-20/h1-17H,18H2,(H,32,33,34)
Standard InChI Key: SQHRNXZOQSGESZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 455.48 | Molecular Weight (Monoisotopic): 455.1609 | AlogP: 7.59 | #Rotatable Bonds: 5 |
Polar Surface Area: 37.81 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 4.40 | CX LogP: 8.23 | CX LogD: 8.23 |
Aromatic Rings: 5 | Heavy Atoms: 34 | QED Weighted: 0.30 | Np Likeness Score: -1.09 |
1. Dexheimer TS, Rosenthal AS, Luci DK, Liang Q, Villamil MA, Chen J, Sun H, Kerns EH, Simeonov A, Jadhav A, Zhuang Z, Maloney DJ.. (2014) Synthesis and structure-activity relationship studies of N-benzyl-2-phenylpyrimidin-4-amine derivatives as potent USP1/UAF1 deubiquitinase inhibitors with anticancer activity against nonsmall cell lung cancer., 57 (19): [PMID:25229643] [10.1021/jm5010495] |
Source(1):